SAGENT PHARMACEUTICALS INC's ticker is SGNT and the CUSIP is 786692103. A total of 98 filers reported holding SAGENT PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2016 | $255,000 | +23.2% | 17,025 | 0.0% | 0.00% | 0.0% |
Q1 2016 | $207,000 | -20.1% | 17,025 | +4.7% | 0.00% | 0.0% |
Q4 2015 | $259,000 | +4.0% | 16,255 | 0.0% | 0.00% | 0.0% |
Q3 2015 | $249,000 | -39.1% | 16,255 | -3.4% | 0.00% | -33.3% |
Q2 2015 | $409,000 | +1.7% | 16,835 | -2.6% | 0.00% | 0.0% |
Q1 2015 | $402,000 | -7.4% | 17,285 | 0.0% | 0.00% | 0.0% |
Q4 2014 | $434,000 | -19.3% | 17,285 | 0.0% | 0.00% | -25.0% |
Q3 2014 | $538,000 | +20.4% | 17,285 | 0.0% | 0.00% | +33.3% |
Q2 2014 | $447,000 | +36.3% | 17,285 | +23.1% | 0.00% | +50.0% |
Q1 2014 | $328,000 | -28.2% | 14,042 | -21.9% | 0.00% | -33.3% |
Q4 2013 | $457,000 | +60.4% | 17,990 | +28.8% | 0.00% | +50.0% |
Q3 2013 | $285,000 | -2.7% | 13,970 | 0.0% | 0.00% | 0.0% |
Q2 2013 | $293,000 | – | 13,970 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Stonepine Capital Management, LLC | 462,824 | $7,364,000 | 8.63% |
HealthCor Management, L.P. | 1,750,000 | $27,843,000 | 1.69% |
ACUTA CAPITAL PARTNERS, LLC | 144,667 | $2,302,000 | 1.10% |
THB ASSET MANAGEMENT | 615,546 | $9,793,000 | 1.05% |
Penn Capital Management Company, LLC | 1,399,205 | $22,261,000 | 0.98% |
Tamarack Advisers, LP | 450,000 | $7,160,000 | 0.94% |
Piermont Capital Management Inc. | 139,020 | $2,212,000 | 0.70% |
JW Asset Management, LLC | 101,630 | $1,617,000 | 0.60% |
SECTORAL ASSET MANAGEMENT INC | 810,362 | $12,893,000 | 0.55% |
Glacier Peak Capital LLC | 50,000 | $796,000 | 0.51% |